Moneycontrol PRO
ipca laboratories
Jump to
391 Results Found
  • Buy Ipca Laboratories; target of Rs 837: Prabhudas Lilladher Mar 09, 2018 04:22 PM IST

    Buy Ipca Laboratories; target of Rs 837: Prabhudas Lilladher

    Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 837 in its research report dated March 09, 2018.

  • Nifty down 10% from highs; top 3 stocks which could give up to 15% return in 3 months Mar 08, 2018 09:41 AM IST

    Nifty down 10% from highs; top 3 stocks which could give up to 15% return in 3 months

    In the current week, selling pressure was intensified on the breach of lower band of the broader consolidation range of 10300.

  • Markets@Moneycontrol: Nifty may open higher; 3 stocks which can give up to 15% return Mar 08, 2018 08:36 AM IST

    Markets@Moneycontrol: Nifty may open higher; 3 stocks which can give up to 15% return

    The Nifty50 is likely to open higher on Thursday tracking positive trend seen in other Asian markets. The index closed 95 points lower at 10,154.

  • Buy Ipca Laboratories; target of Rs 715: ICICI Direct Feb 09, 2018 12:07 PM IST

    Buy Ipca Laboratories; target of Rs 715: ICICI Direct

    ICICI Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 715 in its research report dated February 09, 2018.

  • Ipca acquires US API developer Pisgah Labs for $9.65 mn Jan 17, 2018 10:53 AM IST

    Ipca acquires US API developer Pisgah Labs for $9.65 mn

    In a BSE filing Ipca Laboratories announced "acquisition of 100 per cent share capital of Pisgah Labs Inc, a North Carolina Corporation" by Ipca Pharmaceutical Inc, USA and Onyx Scientific Ltd., U.K (Onyx) (company's wholly owned step down subsidiary) for USD 9.65 million free of debt".

  • Ipca Lab Q2 net profit up 75% at Rs 96 cr Nov 14, 2017 03:25 PM IST

    Ipca Lab Q2 net profit up 75% at Rs 96 cr

    The company had posted a net profit at Rs 54.95 crore during the same period of previous fiscal, Ipca Laboratories said in a regulatory filing.

  • Buy IPCA Laboratories, PC Jeweller: Mitessh Thakkar Oct 04, 2017 03:03 PM IST

    Buy IPCA Laboratories, PC Jeweller: Mitessh Thakkar

    Mitessh Thakkar of miteshthacker.com suggests buying IPCA Laboratories and PC Jeweller.

  • Regulatory issues should reduce going ahead for DRL: Edelweiss Sec Sep 22, 2017 02:20 PM IST

    Regulatory issues should reduce going ahead for DRL: Edelweiss Sec

    Pharma stocks have been on an upward trend. In an interview to CNBC-TV18, Deepak Malik, Pharma Analyst of Edelweiss Securities discussed what is happening in the sector.

  • Ipca Labs Q1 net loss at Rs 20.25 cr Aug 11, 2017 05:15 PM IST

    Ipca Labs Q1 net loss at Rs 20.25 cr

    Net total income of the company also declined to Rs 719.14 crore for the quarter under consideration as against Rs 859.54 crore for the same period a year ago.

  • Ipca to seek US FDA re-audit of Pithampur and Ratlam facilities Aug 07, 2017 02:47 PM IST

    Ipca to seek US FDA re-audit of Pithampur and Ratlam facilities

    Ipca is one of the worst affected companies by the US regulator's action.

  • Ipca says US FDA import ban on drugs relates to change in supply shortage in US Jun 20, 2017 12:03 PM IST

    Ipca says US FDA import ban on drugs relates to change in supply shortage in US

    Drug maker Ipca Laboratories on Tuesday said that US FDA hasn't carried out any new inspections at three of its manufacturing units under scanner.

  • Axis Mutual Fund sells 11.08 lakh shares of Ipca Laboratories Jun 17, 2017 09:19 AM IST

    Axis Mutual Fund sells 11.08 lakh shares of Ipca Laboratories

    Axis Mutual Fund A/C Axis Long Term Equity Fund sold 11,08,795 shares of Ipca Laboratories.

  • Ipca Labs hits 1-yr low on USFDA ban to all drugs manufactured by company Jun 16, 2017 09:20 AM IST

    Ipca Labs hits 1-yr low on USFDA ban to all drugs manufactured by company

    The ban of all drugs will continue until the company can demonstrate that the drugs manufactured sites and intended for the US market are in compliance with Current Good Manufacturing Practice (cGMP).

  • Hold Ipca Laboratories; target of Rs 525: ICICI Direct Jun 01, 2017 04:37 PM IST

    Hold Ipca Laboratories; target of Rs 525: ICICI Direct

    ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 525 in its research report dated May 31, 2017.

  • UBS downgrades Ipca Labs to neutral as earnings growth revival looks priced in Apr 12, 2017 03:28 PM IST

    UBS downgrades Ipca Labs to neutral as earnings growth revival looks priced in

    Given high price erosion in hydroxychloroquine, UBS believes US revenue could continue to be under pressure

  • Bull's Eye: Buy Britannia, Bajaj Corp, SCI; sell Bharat Forge Mar 30, 2017 07:53 AM IST

    Bull's Eye: Buy Britannia, Bajaj Corp, SCI; sell Bharat Forge

    Ashish Kyal of Waves Strategy Advisors advises selling Engineers India with a target of Rs 139.

  • Bull's Eye: Buy Marico, Federal Bank, Cummins, Ipca Lab, HDIL Mar 27, 2017 08:00 AM IST

    Bull's Eye: Buy Marico, Federal Bank, Cummins, Ipca Lab, HDIL

    Ashish Kyal of Waves Strategy Advisors advises buying Century Textiles with a target of Rs 1040.

  • 5 important things about USFDA warning letters, slow resolution Mar 06, 2017 05:02 PM IST

    5 important things about USFDA warning letters, slow resolution

    Warning letters resolutions are taking more time than ever before. Only 9 out of 108 warning letters have been sorted taking an average of 500 days. Data for India and China is even bleaker with just one resolution out of the 64 WLs issued in past 52 months, according to Edelweiss report.

  • Buy Ipca Laboratories; target of Rs 580: Axis Direct Feb 21, 2017 03:11 PM IST

    Buy Ipca Laboratories; target of Rs 580: Axis Direct

    Axis Direct is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 580 in its research report dated February 16, 2017.

  • Hold Ipca Laboratories; target of Rs 560: ICICI Direct Feb 16, 2017 03:23 PM IST

    Hold Ipca Laboratories; target of Rs 560: ICICI Direct

    ICICI Direct recommended hold rating on Ipca Laboratories with a target price of Rs 560 in its research report dated February 13, 2017.

  • Money spinners: 9 stocks IIFL is bullish on for 2017? Jan 14, 2017 02:46 PM IST

    Money spinners: 9 stocks IIFL is bullish on for 2017?

    The brokerage firm says that even on assuming only 12 percent Nifty earnings growth in FY18 due to spill‐over of demonetisation, valuations are factoring much damage at price to earnings (PE) of 17 times.

  • Top buzzing midcap stocks to trade on January 11 Jan 11, 2017 01:43 PM IST

    Top buzzing midcap stocks to trade on January 11

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today -- IndusInd Bank, Shiva Cement, Suzlon Energy and Ipca Laboratories.

  • Ipca says remediation completed at two formulation plants Jan 11, 2017 01:33 PM IST

    Ipca says remediation completed at two formulation plants

    “The third party consultants are regularly visiting our manufacturing units which are under USFDA import alert/warning letter and are assisting us in implementing robust remediation measures in a proper and timely manner,” Ipca said in a clarification to stock exchanges.

  • Bullish on Ipca Lab, see strong earnings growth: Rajesh Kothari Dec 13, 2016 04:15 PM IST

    Bullish on Ipca Lab, see strong earnings growth: Rajesh Kothari

    Rajesh Kothari, Managing Director at AlfAccurate Advisors has a bullish stance on Ipca Laboratories and feels that earnings growth can be very strong over the next 2-3 years.

  • Buy, sell, hold: 5 stocks that you should watch out today Nov 17, 2016 08:47 AM IST

    Buy, sell, hold: 5 stocks that you should watch out today

    Nomura maintains buy call with target unchanged at Rs 900 per share as volumes could improve further and margin may improve in second half.

Sections
ISO 27001 - BSI Assurance Mark